NCT01008358View on ClinicalTrials.gov

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Hepatocellular CarcinomaHepatitis C Virus Chronic Infection

Interventions

BIOLOGICAL

CP 675,206

Trial Locations (3)

Unknown

Hospital Universitario Reina Sofía, Córdoba

Hospital Universitario 12 de Octubre, Madrid

Clinica Universitaria de Navarra, Pamplona

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER